Armistice Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Armistice Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,292,000	Closed	-$9.22M	–	111
2018 Q3	$9.22M	Buy	3,292,000 +3,171,111	+2,623%	+$8.9M	0.55%	45
2018 Q2	$357K	Sell	120,889 -679,111	-85%	-$1.61M	0.02%	70
2018 Q1	$1.8M	Buy	+800,000	New	+$1.87M	0.14%	57
2016 Q3	–	Sell	-2,652,000	Closed	-$6.26M	–	62
2016 Q2	$6.26M	Sell	2,652,000 -60,000	-2%	-$166K	2.38%	16
2016 Q1	$8.76M	Buy	2,712,000 +92,000	+4%	+$340K	3.44%	10
2015 Q4	$12.6M	Buy	2,620,000 +1,140,000	+77%	+$6.46M	4.48%	6
2015 Q3	$8.23M	Buy	1,480,000 +1,080,000	+270%	+$7.97M	2.81%	15
2015 Q2	$3.18M	Buy	+400,000	New	+$3.44M	1.14%	24

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AOWM

Alpha Omega Wealth Management Richmond, Virginia $617M AUM 16.56% 1-Year Est. Return

Armistice Capital's BDSI Position: Q4 2018 in Review

Armistice Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2018, closing a stake of 3,292,000 shares — an estimated $9.22M sold.

Armistice Capital first reported a position in BDSI in Q2 2015 and held it in 8 quarters. The position peaked at $12.6M in Q4 2015. 86 funds tracked by Wall St. Rank hold BDSI as of Q4 2018.

Armistice Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2018 after selling out during the quarter.
Armistice Capital sold 3,292,000 BioDelivery Sciences International, Inc. shares in Q4 2018, an estimated $9.22M.
Armistice Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2015 and held it in 8 quarters.
Armistice Capital's BioDelivery Sciences International, Inc. position peaked at $12.6M in Q4 2015.
86 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2018.

Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.